ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES

The work has studied opportunities for ТЕ EPS in serial testing of antiarrhythmic drugs testing to prevent recurrent arrhythmia in patients with atrial fibrillation. Antiarrhythmic drug adjustment was performed in 85 patients with paroxysmal atrial fibrillation. Serial testing implied the usage of a...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. A. Skiba, V. V. Petry, V. A. Sulimov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2003-06-01
Series:	Российский кардиологический журнал
Subjects:	transesophageal electrophysiological study paroxysms of atrial fibrillation serial testing of antiarrhythmic drugs individual therapy adjustment
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1743
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

STRUCTURAL AND ELECTROPHYSIOLOGICAL PREDICTORS OF A PAROXYSM OF ATRIAL FIBRILLATION
by: B. G. Iskenderov, et al.
Published: (2001-08-01)

DIAGNOSTICS AND TREATMENT OF PAROXYSMAL NODAL RECIPROCATING TACHYCARDIAS WITH TRANSESOPHAGEAL STIMULATION
by: V. V. Petry, et al.
Published: (2002-10-01)

Pediatric antiarrhythmics and toxicity: A clinical review
by: Alexandra T. Geanacopoulos, et al.
Published: (2024-02-01)

Vagal Techniques for Terminating Paroxysmal Tachycardia in Children: Assessment of Clinical Electrophysiological Factors of Valsalva Test Effectiveness
by: T. K. Kruchina, et al.
Published: (2016-02-01)

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare payer perspective
by: Malte Kuniss, et al.
Published: (2024-11-01)

CHARACTERISTICS OF COMBINED USE OF MEXICOR TOGETHER WITH SOME ANTIARRHYTHMIC DRUGS IN ACUTE OCCLUSION OF CORONARY ARTERY IN EXPERIMENTAL STUDY
by: A. A. Kotljarov, et al.
Published: (2003-10-01)

ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICS
by: T. A. Rybakova, et al.
Published: (2018-08-01)

Statins and their antiarrhythmic activity
by: N. Sh. Zagidullin, et al.
Published: (1970-01-01)

Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
by: M. H. Fedorova, et al.
Published: (2018-11-01)

Antiarrhythmic medication classification based on pathogenetic cardiac arrhythmia mechanisms
by: T. N. Lipnitsky, et al.
Published: (2007-12-01)

THE PROPANORM EFFICACY IN RAPID RELIEF OF SYMPTOMS OF PAROXYSMAL AURICULAR FIBRILLATION
by: N. N. Borovkov, et al.
Published: (2003-10-01)

Antiarrhythmic therapy in the treatment of atrial fibrillation: yesterday, today, tomorrow
by: V. I. Podzolkov, et al.
Published: (2019-06-01)

Prediction of antiarrhythmic therapy effectiveness in children
by: L. I. Svintsova, et al.
Published: (2019-08-01)

Propafenone efficacy in paroxysmal atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2004-12-01)

Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice
by: V. L. Doshchitsin, et al.
Published: (2022-07-01)

ASSESSMENT OF ANTIARRHYTHMIC ACTIVITY AND SAFETY OF NEW DERIVATIVES OF MORPHOLINOACETIC ACID
by: I. P. Rudakova, et al.
Published: (2019-01-01)

Antiarrhythmic therapy effects on quality of life among patients with extrasystoles
by: V. L. Doshchitsyn, et al.
Published: (2008-10-01)

Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease
by: D. A. Tsaregorodtsev, et al.
Published: (2023-05-01)

Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry
by: L. E. Korobchenko, et al.
Published: (2020-06-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Study of the antiarrhythmic activity of linear alkoxyphenylazalkanes in the model of reperfusion arrythmias in rats
by: V. V. Barchukov, et al.
Published: (2023-07-01)

THE POSSIBILITIES OF ANTIARRHYTHMIC THERAPY IN PRIMARY PREVENTION OF DEATH IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS
by: Yu. A. Bunin
Published: (2016-01-01)

ANTIISCHEMIC AND ANTIARRHYTHMIC EFFECTS OF SIMVASTATIN IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2013-12-01)

Analysis of fatal outcome structure in acute poisoning with hypotensive and antiarrhythmic drugs
by: K. K. Ilyashenko, et al.
Published: (2024-03-01)

ANTIARRHYTHMIC ACTIVITY MONOGAMISTIC AMIDES AND HYDRAZIDES 1,4-DICARBOXYLIC ACIDS
by: N. V. Kolotova, et al.
Published: (2019-01-01)

Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs
by: B. A. Tatarsky, et al.
Published: (2021-08-01)

Antiarrhythmic therapy for atrial fibrillation: current guidelines of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery (ESC/EACTS)
by: A. I. Tarzimanova, et al.
Published: (2021-09-01)

Clinical study of Russian class III antiarrhythmic agent, nibentan, in supraventricular arrhythmia management
by: V. G. Valiev, et al.
Published: (2005-12-01)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015-12-01)

Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs
by: E. A. Ushkalova, et al.
Published: (2016-11-01)

Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs
by: E. A. Ushkalova, et al.
Published: (2016-09-01)

Ventricular tachycardia and myocardial infarction during antiarrhythmic therapy: a case report
by: A. A. Gurbanova, et al.
Published: (2023-07-01)

Antiarrhythmic therapy choice in patients with left ventricular diastolic dysfunction and atrial fibrillation
by: A. V. Tarasov, et al.
Published: (1970-01-01)

Antiarrhythmic drug use in atrial fibrillation among different European countries – as determined by a physician survey
by: Espen Fengsrud, et al.
Published: (2025-08-01)

Comparing the Impact of Different Antiarrhythmic Classes on Clinical Outcomes Following Atrial Fibrillation Catheter Ablation
by: Andrej Belančić, et al.
Published: (2025-07-01)

ASSOCIATION OF RS2200733 POLYMORPHISM WITH ANTIARRHYTHMIC THERAPY AND PROGRESSION OF ATRIAL FIBRILLATION IN THE UZBEK POPULATIO
by: R. D. Kurbanov, et al.
Published: (2020-12-01)

Clinical and Psychological Features of Patients With Poisoning By Antihypertensive and Antiarrhythmic Drugs as a Result of Suicidal Actions
by: A. B. Kholmogorova, et al.
Published: (2023-02-01)

Clinical and Psychopathological Features of Mental Disorders in Patients with Poisoning by Hypotensive and Antiarrhythmic Drugs as a Result of Suicidal Acts
by: T. I. Dikaya, et al.
Published: (2024-01-01)

NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

Machine-learning model for predicting left atrial thrombus in patients with paroxysmal atrial fibrillation
by: Wanli Xiong, et al.
Published: (2025-06-01)